About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Investors
Share price
Annual reports
Shareholder newsletter
Analyst coverage
Corporate governance
Corporate policies
Contact us
About us
Our team
Our science
Radiopharmaceuticals
Our technology
Abstracts & publications
Our pipeline
News
All news
ASX releases
Media releases
Investors
Share price
Shareholder newsletter
Analyst coverage
Corporate governance
Corporate policies
Contact us
Radiopharm Theranostics
Click here for the latest stock information
Innovating the way we see and treat cancer
VIDEO
Radiopharm Theranostics panel discusses latest progress and understanding of radiopharmaceutical sector
PLAY
LATEST NEWS
FDA Pre-IND Meeting Supports an IND Application for RAD101
Read more
Read more
LATEST NEWS
RAD Receives FDA Orphan Drug Designation for Trivehexin (RAD301) in Pancreatic Cancer
Read more
Read more
We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.
Our technology
The unique potential of Radiopharmaceuticals in treating oncological diseases.
Learn more
Our pipeline
The unique potential of being
First to Market
or
Best in Class.
Learn more
Our team
We have a unique commitment to improve patients’ hope in fighting cancer.
Learn more
Information for investors
Stock price, Company governance & updates from our multiple development programs.
Learn more
Latest news
ASX Releases
May 29, 2023
FDA Pre-IND Meeting Supports an IND Application for RAD101
Read more
Read more
ASX Releases
May 9, 2023
RAD Receives FDA Orphan Drug Designation for Trivehexin (RAD301) in Pancreatic Cancer
Read more
Read more
Media Coverage
May 2, 2023
Positive new publication for RAD301 platform
Read more
Read more
Sign up to our mailing list.
Receive all the latest news from Radiopharm Theranostics.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please fill out all starred fields.